lysine has been researched along with cudc-907 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Assouline, SE; Cerchietti, L; Krumsiek, J; Mann, KK; Marullo, R; Patel, J; Pera, B; Phillip, JM; Román, L | 1 |
2 other study(ies) available for lysine and cudc-907
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway.
Topics: Animals; Cell Line, Tumor; Cellular Reprogramming; Choline; Choline Kinase; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma, Large B-Cell, Diffuse; Lysine; Male; Metabolome; Metabolomics; Mice; Morpholines; Panobinostat; Pyrimidines; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |